ישראל - עברית - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

ישראל - עברית - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine

ישראל - עברית - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine

ישראל - עברית - Ministry of Health

romat ltd - ferrous as dextran - תמיסה להזרקה - ferrous as dextran 100 mg/ml

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - deferiprone - טבליות מצופות פילם - deferiprone 500 mg - deferiprone - deferiprone - for the treatment of iron overload in patients over 6 years old with thalassaemia major when deferoxamine therapy is contraindicated or inadequate.

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - deferiprone - תמיסה (פומי) - deferiprone 100 mg / 1 ml - deferiprone - deferiprone - for the treatment of iron overload in patients over 6 years old with thalassaemia major when deferoxamine therapy is contraindicated or inadequate.